| Overview of the IL-1 family in innate inflammation and acquired immunity |
176 |
| Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family |
98 |
| Mast cells as sources of cytokines, chemokines, and growth factors |
92 |
| Interleukin-18: Biological properties and role in disease pathogenesis |
54 |
| IL-1 and IL-1 regulatory pathways in cancer progression and therapy |
51 |
| The AIM2 inflammasome: Sensor of pathogens and cellular perturbations |
50 |
| Metabolic regulation of NLRP3 |
46 |
| The NLRC4 Inflammasome |
41 |
| The family of the interleukin-1 receptors |
37 |
| Suppression of inflammation and acquired immunity by IL-37 |
37 |
| Regulation and function of interleukin-36 cytokines |
35 |
| The group 2 innate lymphoid cell (ILC2) regulatory network and its underlying mechanisms |
35 |
| Immune checkpoint inhibitors: The linchpins of modern immunotherapy |
32 |
| STING pathway agonism as a cancer therapeutic |
27 |
| Innate immune memory: An evolutionary perspective |
27 |
| Non-IgE mediated mast cell activation |
26 |
| The role of cytokines in T-cell memory in health and disease |
24 |
| Dynamic balance of pro- and anti-inflammatory signals controls disease and limits pathology |
24 |
| The role and relevance of mast cells in urticaria |
24 |
| Autophagy limits activation of the inflammasomes |
23 |
| Mast cell-neural interactions contribute to pain and itch |
23 |
| Tissue-resident memory T cells in tissue homeostasis, persistent infection, and cancer surveillance |
23 |
| T cell receptor-based cancer immunotherapy: Emerging efficacy and pathways of resistance |
22 |
| The controversial role of mast cells in fibrosis |
22 |
| The role of the interleukin-1 family in trained immunity |
21 |
| Human mast cells and basophils-How are they similar how are they different? |
21 |
| T follicular helper cell heterogeneity: Time, space, and function |
21 |
| Emerging insights into human health and NK cell biology from the study of NK cell deficiencies |
20 |
| Generation of memory B cells and their reactivation |
20 |
| Function and regulation of IL-1 alpha in inflammatory diseases and cancer |
20 |
| T-cell exhaustion in HIV infection |
19 |
| Newborn screening for severe combined immunodeficiency and T-cell lymphopenia |
19 |
| CAR T cells for brain tumors: Lessons learned and road ahead |
18 |
| Updates on CAR T-cell therapy in B-cell malignancies |
18 |
| Germinal center-derived lymphomas: The darkest side of humoral immunity |
18 |
| Concepts of GPCR-controlled navigation in the immune system |
18 |
| Is it time for a new classification of mast cells? What do we know about mast cell heterogeneity? |
18 |
| Biology of IL-38 and its role in disease |
17 |
| mTOR and other effector kinase signals that impact T cell function and activity |
17 |
| Extrafollicular responses in humans and SLE |
17 |
| Linking signaling and selection in the germinal center |
16 |
| Tuning inflammation and immunity by the negative regulators IL-1R2 and IL-1R8 |
16 |
| The contribution of mast cells to bacterial and fungal infection immunity |
16 |
| The (gradual) rise of memory inflation |
15 |
| Neuroendocrine regulation of innate lymphoid cells |
15 |
| Signaling pathways involved in the T-cell-mediated immunity against Epstein-Barr virus: Lessons from genetic diseases |
15 |
| The function and dysfunction of memory CD8(+) T cells in tumor immunity |
15 |
| Predicting the spectrum of TCR repertoire sharing with a data-driven model of recombination |
15 |
| Primary immunodeficiencies reveal the essential role of tissue neutrophils in periodontitis |
14 |
| Chromosome 22q11.2 deletion syndrome and DiGeorge syndrome |
14 |
